163 related articles for article (PubMed ID: 2539817)
1. Determination and metabolism of dithiol chelating agents. IV. Urinary excretion of meso-2,3-dimercaptosuccinic acid and mercaptosuccinic acid in rabbits given meso-2,3-dimercaptosuccinic acid.
Maiorino RM; Aposhian HV
Biochem Pharmacol; 1989 Apr; 38(7):1147-54. PubMed ID: 2539817
[TBL] [Abstract][Full Text] [Related]
2. Determination and metabolism of dithiol-chelating agents: electrolytic and chemical reduction of oxidized dithiols in urine.
Maiorino RM; Barry TJ; Aposhian HV
Anal Biochem; 1987 Jan; 160(1):217-26. PubMed ID: 3032019
[TBL] [Abstract][Full Text] [Related]
3. Determination and metabolism of dithiol chelating agents. VI. Isolation and identification of the mixed disulfides of meso-2,3-dimercaptosuccinic acid with L-cysteine in human urine.
Maiorino RM; Bruce DC; Aposhian HV
Toxicol Appl Pharmacol; 1989 Feb; 97(2):338-49. PubMed ID: 2538007
[TBL] [Abstract][Full Text] [Related]
4. Urinary excretion of meso-2,3-dimercaptosuccinic acid in human subjects.
Aposhian HV; Maiorino RM; Dart RC; Perry DF
Clin Pharmacol Ther; 1989 May; 45(5):520-6. PubMed ID: 2541962
[TBL] [Abstract][Full Text] [Related]
5. Determination and metabolism of dithiol chelating agents: X. In humans, meso-2,3-dimercaptosuccinic acid is bound to plasma proteins via mixed disulfide formation.
Maiorino RM; Akins JM; Blaha K; Carter DE; Aposhian HV
J Pharmacol Exp Ther; 1990 Aug; 254(2):570-7. PubMed ID: 2166796
[TBL] [Abstract][Full Text] [Related]
6. Determination and metabolism of dithiol chelating agents. VII. Biliary excretion of dithiols and their interactions with cadmium and metallothionein.
Zheng W; Maiorino RM; Brendel K; Aposhian HV
Fundam Appl Toxicol; 1990 Apr; 14(3):598-607. PubMed ID: 2160390
[TBL] [Abstract][Full Text] [Related]
7. Determination and metabolism of dithiol chelating agents. XII. Metabolism and pharmacokinetics of sodium 2,3-dimercaptopropane-1-sulfonate in humans.
Maiorino RM; Dart RC; Carter DE; Aposhian HV
J Pharmacol Exp Ther; 1991 Nov; 259(2):808-14. PubMed ID: 1941628
[TBL] [Abstract][Full Text] [Related]
8. Determination and metabolism of dithiol chelating agents. XV. The meso-2,3-dimercaptosuccinic acid-cysteine (1:2) mixed disulfide, a major urinary metabolite of DMSA in the human, increases the urinary excretion of lead in the rat.
Maiorino RM; Aposhian MM; Xu ZF; Li Y; Polt RL; Aposhian HV
J Pharmacol Exp Ther; 1993 Dec; 267(3):1221-6. PubMed ID: 8263783
[TBL] [Abstract][Full Text] [Related]
9. The presence of lead decreases the availability of meso-2, 3-dimercaptosuccinic acid for analysis in the monobromobimane assay.
Lever SZ; Parsons TL
Chem Res Toxicol; 1999 Nov; 12(11):1057-65. PubMed ID: 10563831
[TBL] [Abstract][Full Text] [Related]
10. Determination and metabolism of dithiol chelating agents. VIII. Metal complexes of meso-dimercaptosuccinic acid.
Rivera M; Zheng W; Aposhian HV; Fernando Q
Toxicol Appl Pharmacol; 1989 Aug; 100(1):96-106. PubMed ID: 2548305
[TBL] [Abstract][Full Text] [Related]
11. Influence of 2,3-dimercaptopropane-1-sulfonate (DMPS) and meso-2,3-dimercaptosuccinic acid (DMSA) on the renal disposition of mercury in normal and uninephrectomized rats exposed to inorganic mercury.
Zalups RK
J Pharmacol Exp Ther; 1993 Nov; 267(2):791-800. PubMed ID: 8246154
[TBL] [Abstract][Full Text] [Related]
12. Dimercaptan metal-binding agents influence the biotransformation of arsenite in the rabbit.
Maiorino RM; Aposhian HV
Toxicol Appl Pharmacol; 1985 Feb; 77(2):240-50. PubMed ID: 2983455
[TBL] [Abstract][Full Text] [Related]
13. Determination and metabolism of dithiol chelating agents. III. Formation of oxidized metabolites of 2,3-dimercaptopropane-1-sulfonic acid in rabbit.
Maiorino RM; Weber GL; Aposhian HV
Drug Metab Dispos; 1988; 16(3):455-63. PubMed ID: 2900740
[TBL] [Abstract][Full Text] [Related]
14. 2,3-Dimercaptopropane-1-sulfonic acid and meso-2,3-dimercaptosuccinic acid increase mercury- and cadmium-induced inhibition of delta-aminolevulinate dehydratase.
Nogueira CW; Soares FA; Nascimento PC; Muller D; Rocha JB
Toxicology; 2003 Mar; 184(2-3):85-95. PubMed ID: 12499112
[TBL] [Abstract][Full Text] [Related]
15. Human studies with the chelating agents, DMPS and DMSA.
Aposhian HV; Maiorino RM; Rivera M; Bruce DC; Dart RC; Hurlbut KM; Levine DJ; Zheng W; Fernando Q; Carter D
J Toxicol Clin Toxicol; 1992; 30(4):505-28. PubMed ID: 1331491
[TBL] [Abstract][Full Text] [Related]
16. Antidotal effects of 2,3-dimercaptopropane-1-sulfonic acid (DMPS) and meso-2,3-dimercaptosuccinic acid (DMSA) on the organotoxicity of dibutyltin dichloride (DBTC) in rats.
Merkord J; Weber H; Kröning G; Hennighausen G
Hum Exp Toxicol; 2000 Feb; 19(2):132-7. PubMed ID: 10773844
[TBL] [Abstract][Full Text] [Related]
17. Multidrug resistance proteins and the renal elimination of inorganic mercury mediated by 2,3-dimercaptopropane-1-sulfonic acid and meso-2,3-dimercaptosuccinic acid.
Bridges CC; Joshee L; Zalups RK
J Pharmacol Exp Ther; 2008 Jan; 324(1):383-90. PubMed ID: 17940195
[TBL] [Abstract][Full Text] [Related]
18. meso-2,3-Dimercaptosuccinic acid: chemical, pharmacological and toxicological properties of an orally effective metal chelating agent.
Aposhian HV; Aposhian MM
Annu Rev Pharmacol Toxicol; 1990; 30():279-306. PubMed ID: 2160791
[TBL] [Abstract][Full Text] [Related]
19. Relationships between the renal handling of DMPS and DMSA and the renal handling of mercury.
Zalups RK; Bridges CC
Chem Res Toxicol; 2012 Sep; 25(9):1825-38. PubMed ID: 22667351
[TBL] [Abstract][Full Text] [Related]
20. Mobilization of heavy metals by newer, therapeutically useful chelating agents.
Aposhian HV; Maiorino RM; Gonzalez-Ramirez D; Zuniga-Charles M; Xu Z; Hurlbut KM; Junco-Munoz P; Dart RC; Aposhian MM
Toxicology; 1995 Mar; 97(1-3):23-38. PubMed ID: 7716789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
